phorbol-12-myristate has been researched along with arginine in 1 studies
| Studies (phorbol-12-myristate) | Trials (phorbol-12-myristate) | Recent Studies (post-2010) (phorbol-12-myristate) | Studies (arginine) | Trials (arginine) | Recent Studies (post-2010) (arginine) |
|---|---|---|---|---|---|
| 128 | 0 | 79 | 46,388 | 1,688 | 11,176 |
| Protein | Taxonomy | phorbol-12-myristate (IC50) | arginine (IC50) |
|---|---|---|---|
| Cationic amino acid transporter 3 | Homo sapiens (human) | 283 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chitnis, T; De Jager, PL; Frohlich, IY; Guttmann, CR; Hafler, DA; Healy, BC; Keenan, BT; Khoury, SJ; Lee, M; Ottoboni, L; Weiner, HL; Xia, Z | 1 |
1 other study(ies) available for phorbol-12-myristate and arginine
| Article | Year |
|---|---|
Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus.
Topics: Animals; Arginine; Chemokine CXCL10; Female; Gene Expression Regulation; Genetic Predisposition to Disease; Genotype; Glutamine; HEK293 Cells; Humans; Immunologic Factors; Longitudinal Studies; Male; Monocytes; Multiple Sclerosis; Mutation; Phorbol Esters; Receptors, Tumor Necrosis Factor, Type I; RNA Isoforms; Signal Transduction; Tumor Necrosis Factor-alpha | 2013 |